High-Risk Pregnancy — Causes, Symptoms, Monitoring & Management Guide — Symptoms, Causes & Treatment | MyMedicPlus

A high-risk pregnancy is one in which the health of the mother, fetus, or both is at increased risk compared with a low-risk pregnancy, requiring enhanced surveillance and specialist obstetric care. There is no single definition — risk stratification is performed at booking and throughout pregnancy using validated tools. High-risk pregnancies arise from three main categories: pre-existing maternal medical conditions (diabetes, hypertension, cardiac disease, epilepsy, autoimmune disorders, renal disease, mental health conditions), pregnancy-specific complications (pre-eclampsia, gestational diabetes, placenta praevia, intrauterine growth restriction — IUGR, preterm labour), and obstetric history or fetal factors (previous stillbirth, recurrent miscarriage, multiple pregnancy, advanced maternal age above 35, fetal anomalies, alloimmunisation). The goal of high-risk pregnancy management is early risk identification, preventive interventions where available (aspirin for pre-eclampsia, folic acid for neural tube defects), enhanced monitoring for early detection of complications, and planned timely delivery to optimise outcomes for mother and baby.

Pre-existing maternal conditions: hypertension (essential hypertension before 20 weeks is a major risk factor for superimposed pre-eclampsia and placental abruption), type 1 and type 2 diabetes (congenital anomalies, macrosomia, stillbirth, pre-eclampsia), cardiac disease (particularly congenital heart disease, cardiomyopathy, valve disease — maternal mortality risk varies by lesion severity; CARPREG risk score guides management), epilepsy (seizures in pregnancy; teratogenicity of antiepileptic drugs — sodium valproate contraindicated in pregnancy due to high teratogenic risk up to 10% and neurodevelopmental harm; lamotrigine and levetiracetam preferred), systemic lupus erythematosus (SLE — flares, pre-eclampsia, IUGR, neonatal lupus), antiphospholipid syndrome (recurrent miscarriage, thrombosis, pre-eclampsia), thyroid disorders, chronic kidney disease (accelerated renal deterioration, pre-eclampsia, preterm birth), and HIV (maternal-to-child transmission prevention). Pregnancy-specific complications: pre-eclampsia (new-onset hypertension above 140/90 mmHg after 20 weeks with proteinuria or organ dysfunction — can progress to severe pre-eclampsia, HELLP syndrome, eclampsia), gestational diabetes (macrosomia, shoulder dystocia, neonatal hypoglycaemia, increased caesarean risk), placenta praevia (low-lying placenta covering the cervical os — painless antepartum haemorrhage, requires elective caesarean), placental abruption (premature separation — painful haemorrhage, fetal distress, maternal shock), PPROM (preterm prelabour rupture of membranes — infection risk, cord prolapse, preterm delivery). Demographic and obstetric factors: advanced maternal age (above 35 — chromosomal abnormalities, pre-eclampsia, stillbirth, placenta praevia), obesity (BMI above 30 — all complications more common), multiple pregnancy (preterm labour, IUGR, TTTS — twin-to-twin transfusion syndrome), recurrent miscarriage, previous caesarean, grand multiparity.

Symptoms requiring urgent assessment at any point in pregnancy: severe headache (pre-eclampsia — occipital or frontal; associated with visual disturbance), visual changes (flashing lights, blurring, or loss of vision — pre-eclampsia), upper abdominal or epigastric pain (HELLP syndrome — haemolysis, elevated liver enzymes, low platelets; a dangerous complication of pre-eclampsia), sudden significant swelling of face, hands, or feet (pathological oedema of pre-eclampsia — distinct from normal pregnancy swelling), reduced fetal movements (may indicate fetal compromise — any reduction from the individual's normal pattern should be assessed; contact maternity unit immediately rather than waiting), vaginal bleeding (placenta praevia — painless; placental abruption — painful; any bleeding requires urgent assessment), severe abdominal pain with or without bleeding (abruption), leakage of fluid (PPROM — requires hospitalisation and monitoring), severe itching of the palms and soles especially at night (obstetric cholestasis — bile salt accumulation increases stillbirth risk), fever with uterine tenderness (chorioamnionitis).

Booking bloods (first antenatal appointment): FBC, blood group and antibody screen, rubella immunity, HIV, syphilis, hepatitis B, haemoglobin electrophoresis (sickle cell and thalassaemia carrier screening), urine culture, blood pressure. First trimester screening (11-14 weeks): combined test (nuchal translucency scan + PAPP-A + free beta-hCG) for trisomies 21, 18, and 13; cell-free fetal DNA (NIPT — higher sensitivity and specificity, available NHS for high-risk results). First trimester pre-eclampsia screening (FMFUK model at 11-14 weeks): maternal factors + mean arterial pressure + uterine artery Doppler pulsatility index + PAPP-A + placental growth factor (PlGF) — identifies women who will benefit from aspirin 150 mg nightly from 12 weeks (reduces preterm pre-eclampsia by 62% — ASPRE trial). Fetal anomaly ultrasound scan at 18-20 weeks. Serial growth and liquor volume scans (every 2-4 weeks from 26-28 weeks for IUGR, multiple pregnancy, diabetes, hypertension). Uterine artery and umbilical artery Doppler (IUGR monitoring — absent or reversed end-diastolic flow indicates delivery planning). OGTT (75 g, 2-hour test at 24-28 weeks) for gestational diabetes screening in risk groups (BMI above 30, previous GDM, family history type 2 diabetes, previous macrosomic baby, South Asian ethnicity). Blood pressure monitoring at every antenatal visit; home monitoring for hypertensive women. CTG (cardiotocography) for acute fetal assessment and inpatient monitoring.

Pre-eclampsia prevention: aspirin 150 mg nightly from 12 weeks until 36 weeks for women at high risk (FMFUK screening or clinical risk factor-based — reduces preterm pre-eclampsia by 62%, ASPRE 2017). Established pre-eclampsia: antihypertensives (labetalol — first-line; nifedipine; methyldopa); magnesium sulphate (prevents eclamptic seizures — 4 g IV loading; reduces maternal mortality; also given for fetal neuroprotection in preterm birth before 30 weeks); definitive treatment is delivery — timing based on severity and gestation. Gestational diabetes: dietary modification (reduced carbohydrate, low GI diet) and blood glucose monitoring first-line (targets: fasting below 5.3 mmol/L, 1-hour post-meal below 7.8 mmol/L); metformin (NICE-endorsed off-label) or insulin if targets not achieved; aspirin for pre-eclampsia prevention; induction of labour at 38-39 weeks. IUGR: enhanced Doppler surveillance; antenatal corticosteroids (betamethasone 12 mg IM x2 doses 24 hours apart) for lung maturation when preterm delivery anticipated before 35 weeks; planned delivery timing guided by fetal Doppler and condition. Preterm labour: tocolytics (nifedipine — 48 hours to allow steroid administration and in utero transfer to appropriate unit); antenatal corticosteroids; magnesium sulphate for fetal neuroprotection (below 30 weeks); GBS intrapartum antibiotic prophylaxis if positive. Multiple pregnancy: increased monitoring frequency; fetoscopic laser ablation of vascular anastomoses for twin-to-twin transfusion syndrome (TTTS). Cardiac disease in pregnancy: multidisciplinary pre-conception counselling and joint cardiology-obstetric care from booking.

High-risk pregnancies carry significantly elevated rates of maternal and perinatal complications. Maternal complications: pre-eclampsia and eclampsia affect 5–8% of high-risk pregnancies; HELLP syndrome (haemolysis, elevated liver enzymes, low platelets) is a life-threatening variant; postpartum haemorrhage (PPH — blood loss above 500 mL after vaginal delivery) is more common with macrosomia, multiple pregnancy, and operative delivery; peripartum cardiomyopathy occurs disproportionately in women with prior cardiac disease or multiple pregnancy; thromboembolic events (DVT, pulmonary embolism) — pregnancy is a prothrombotic state and risk is highest postpartum, particularly after caesarean section. Fetal and neonatal complications: intrauterine growth restriction (IUGR) increases risk of fetal hypoxia, stillbirth, and neonatal metabolic complications; preterm birth (spontaneous or iatrogenic) is the leading cause of perinatal mortality and morbidity — prematurity causes neurodisability, respiratory distress syndrome, necrotising enterocolitis, sepsis, and retinopathy of prematurity; congenital anomalies occur at higher rates in diabetic pregnancies and chromosomal conditions; neonatal hypoglycaemia and polycythaemia are more common in macrosomic diabetic babies. Stillbirth rate is 3–5 times higher in some high-risk pregnancy categories than low-risk pregnancies. Psychological complications: anxiety and depression are significantly more prevalent in women experiencing high-risk pregnancies — anticipatory grief, fear of adverse outcomes, prolonged hospitalisation, and traumatic birth experiences all contribute to perinatal mental health morbidity requiring proactive assessment and support.

Pre-conception care is the most effective intervention for reducing risk in high-risk pregnancies. Women with known medical conditions should see their GP and relevant specialists before conception: optimise disease control, review medication safety in pregnancy (sodium valproate must be avoided in women of childbearing potential; ACE inhibitors and ARBs are contraindicated in pregnancy — switch to labetalol or methyldopa before conception), and achieve a healthy weight. Folic acid: 400 mcg daily (5 mg daily for women on antiepileptics, with diabetes, or BMI above 30) from pre-conception to 12 weeks — prevents neural tube defects (approximately 70% reduction). Aspirin 150 mg nightly from 12 weeks for women at high pre-eclampsia risk. Achieve healthy weight before pregnancy (BMI below 30) — obesity is the single most modifiable risk factor for gestational diabetes, pre-eclampsia, and stillbirth. Smoking cessation. Check rubella immunity before conception (live vaccine contraindicated in pregnancy). Optimise glycaemic control in type 1 and 2 diabetes pre-conception (HbA1c below 48 mmol/mol ideally — reduces congenital anomaly risk significantly).

Contact your maternity unit immediately (24-hour triage line) for: any reduction in fetal movements from your normal pattern; vaginal bleeding (any amount, with or without pain); severe headache or visual disturbances; severe upper abdominal or epigastric pain; sudden significant swelling of face, hands, or feet; continuous abdominal pain or contractions before 37 weeks (possible preterm labour); leakage of amniotic fluid; or fever with chills and uterine tenderness. Do not wait to see your GP — go directly to the obstetric triage unit at your hospital. These symptoms may indicate pre-eclampsia, placental abruption, preterm labour, or fetal distress — all requiring immediate assessment. Trust your instincts about changes in fetal movements: if something feels wrong, seek assessment. The 24-hour maternity helpline number should be in your antenatal notes from your first appointment.